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ABSTRACT
Optogenetics is a constellation of optics, genetics, and bioengineering which 
unites genetic engineering with optics to determine and manage the function of 
genetically-targeted groups of cells with light, often in the intact animal, via light-
sensitive microbial membrane proteins (opsins). Light-sensitive genes, especially 
the genetically targeted light-gated channels channelrhodopsin-2 (ChR2) and 
halorhodopsin (NpHR), results in intracellular ion flow during optical illumination. 
Afterwards, the neurons encounter a series of changes resulting from membrane 
depolarization or hyperpolarization. Despite its neuroscience roots, optogenetics 
could potentially be applied in neuropsychocardioncology (neurology, psychiatry, 
oncology, and cardiology). This critical review will explicate a comprehensive 
summary of the roles of optogenetics in the field of neuropsychocardioncology. 
Optogenetics can be potentially developed as neuroprosthetics and direct NpHR 
in the management of spastic movement disorders. Optogenetics can help 
controlling laryngeal muscles contractions in vivo, using both transgenic ChR2-
expressing mice and viral transduction of muscle. The efficacy of optogenetics 
has been proven in epilepsy. Transduction of pyramidal cells in the cortex 
with halorhodopsin and photoinhibition of the neurons were found to decrease 
electrical seizure activity. Optogenetics and DREADD technologies are in their 
early stages, particularly with respect to PD research or therapy. Behavioral 
deficits in autism and schizophrenia might arise from the elevation of cellular 
balance during excitation/inhibition (E/I balance) within neuronal microcircuits. 
This hypothesis was tested by optogenetically elevating the E/I balance in the 
medial-prefrontal cortex using a step-function opsin (SSFO), as well as red-
shifted opsins (C1V1). Increased excitation in excitatory pyramidal neurons leads 
to social-cognitive dysfunction, which are similar to those seen in autism. Cortical 
gamma oscillations are also an indicator of enhanced information processing, 
which is highly affected in schizophrenic patients. Using optogenetic technology, 
researchers were able to characterize the impacts of phosphatidylinositol 3-kinase 
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(PI3K) in Rac1-dependent lamellipodial motility in PC-3 prostate cancer cells. With 
its downstream action on Rac1, PI3K has an important role in the initiation of 
lamellipodial extension, which contributes to prostate cancer cell invasion and 
metastasis. As in Parkinson’s disease, human cells can be engineered to deliver 
the excitatory (hM3Dq receptor) and/or the inhibitory (hM4Di receptor) signals 
to regulate the extent of cellular activity. The optogenetic TCU (tandem-cell-
unit) strategy could be valuable in assessing grafted tissue integration and cell 
delivery in the myocardium during cardiac tissue repair procedures. Low-energy 
pacing strategies could be analyzed by optogenetic investigations. In addition, 
optical stimulation could also be utilized to assess the strategic structures of 
the conduction system. Optogenetic studies have contributed to a better 
understanding of the neural circuits affected in many disorders. A conceptual and 
mutual understanding of multidisciplinary approaches and collaborations would 
enable researchers, clinicians, stakeholders, and the government to develop and 
apply optogenetics in comprehensive medical services and health care. 
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